OpGen (OPGN) Stock Forecast, Price Target & Predictions
OPGN Stock Forecast
OpGen stock forecast is as follows: an average price target of $0.67 (represents a -70.09% downside from OPGN’s last price of $2.24) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
OPGN Price Target
The average price target for OpGen (OPGN) is $0.67 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $0.67 to $0.67. This represents a potential -70.09% downside from OPGN's last price of $2.24.
OPGN Analyst Ratings
According to 1 Wall Street analysts, OpGen's rating consensus is 'Buy'. The analyst rating breakdown for OPGN stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
OpGen Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 11, 2022 | Ben Haynor | Industrial Alliance Securities | $0.67 | $0.61 | 9.25% | -70.09% |
The latest OpGen stock forecast, released on Jul 11, 2022 by Ben Haynor from Industrial Alliance Securities, set a price target of $0.67, which represents a 9.25% increase from the stock price at the time of the forecast ($0.61), and a -70.09% decrease from OPGN last price ($2.24).
OpGen Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $2.24 | $2.24 | $2.24 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of OpGen stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to OpGen's last price of $2.24. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jul 11, 2022 | Alliance Global Partners | - | Buy | Downgrade |
OpGen's last stock rating was published by Alliance Global Partners on Jul 11, 2022. The company Downgrade its OPGN rating from "null" to "Buy".
OpGen Financial Forecast
OpGen Revenue Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 | Sep 17 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | $699.02K | - | $913.44K | $721.63K | $448.71K | $967.21K | $469.75K | $1.43M | $1.24M | $811.62K | $829.72K | $1.35M | $1.06M | $1.19M | $616.93K | $820.67K | $648.22K | $1.01M | $1.02M | $758.96K | $552.22K | $788.90K | $846.23K | $745.11K | $703.21K |
| Avg Forecast | $2.10M | $1.80M | $1.50M | $1.20M | $1.00M | $900.00K | $900.00K | $1.60M | $600.00K | $400.00K | $1.00M | $1.05M | $1.40M | $1.10M | $1.13M | $1.33M | $1.30M | $1.00M | $1.20M | $600.00K | $900.00K | $900.00K | $1.02M | $1.11M | $613.63K | $573.06K | $831.58K | $952.00K | $750.00K | $746.67K |
| High Forecast | $2.10M | $1.80M | $1.50M | $1.20M | $1.00M | $900.00K | $900.00K | $1.60M | $600.00K | $400.00K | $1.00M | $1.05M | $1.40M | $1.10M | $1.13M | $1.33M | $1.30M | $1.00M | $1.20M | $600.00K | $900.00K | $900.00K | $1.02M | $1.11M | $736.35K | $687.67K | $997.89K | $1.14M | $900.00K | $896.00K |
| Low Forecast | $2.10M | $1.80M | $1.50M | $1.20M | $1.00M | $900.00K | $900.00K | $1.60M | $600.00K | $400.00K | $1.00M | $1.05M | $1.40M | $1.10M | $1.13M | $1.33M | $1.30M | $1.00M | $1.20M | $600.00K | $900.00K | $900.00K | $1.02M | $1.11M | $490.90K | $458.44K | $665.26K | $761.60K | $600.00K | $597.33K |
| # Analysts | - | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | - | 9 | 10 | 16 | 9 | 10 | 8 | 8 | 11 | 8 | 18 | 16 | 8 | 18 | 8 | 18 |
| Surprise % | - | - | - | - | - | 0.78% | - | 0.57% | 1.20% | 1.12% | 0.97% | 0.45% | 1.02% | 1.13% | 0.72% | 0.62% | 1.04% | 1.06% | 0.99% | 1.03% | 0.91% | 0.72% | 0.99% | 0.92% | 1.24% | 0.96% | 0.95% | 0.89% | 0.99% | 0.94% |
OpGen's average Quarter revenue forecast for Dec 23 based on 1 analysts is $1.00M, with a low forecast of $1.00M, and a high forecast of $1.00M. OPGN's average Quarter revenue forecast represents a 43.06% increase compared to the company's last Quarter revenue of $699.02K (Sep 23).
OpGen EBITDA Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 | Sep 17 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | - | 9 | 10 | 16 | 9 | 10 | 8 | 8 | 11 | 8 | 18 | 16 | 8 | 18 | 8 | 18 |
| EBITDA | - | - | - | - | - | $-3.19M | - | $-4.69M | $-4.54M | $-6.20M | $-5.26M | $-5.33M | $-5.18M | $-4.02M | $-5.15M | $-13.14M | $-5.13M | $-5.78M | $-5.74M | $-3.68M | $-2.24M | $-3.20M | $-2.33M | $-3.57M | $-3.46M | $-3.04M | $-3.12M | $-2.84M | $-3.00M | $-3.99M |
| Avg Forecast | $-2.10M | $-1.80M | $-1.50M | $-14.86M | $-1.00M | $-900.00K | $-900.00K | $-13.51M | $-600.00K | $-5.12M | $-1.00M | $-12.28M | $-3.34M | $-4.65M | $-5.15M | $-13.14M | $-1.30M | $-5.14M | $-5.97M | $-2.36M | $-900.00K | $-2.50M | $-2.60M | $-2.37M | $-2.64M | $-3.15M | $-3.27M | $-3.14M | $-3.38M | $-4.24M |
| High Forecast | $-2.10M | $-1.80M | $-1.50M | $-11.89M | $-1.00M | $-900.00K | $-900.00K | $-10.81M | $-600.00K | $-4.09M | $-1.00M | $-9.83M | $-2.67M | $-3.72M | $-4.12M | $-10.51M | $-1.30M | $-4.11M | $-4.77M | $-1.89M | $-900.00K | $-2.00M | $-2.08M | $-1.89M | $-2.11M | $-2.52M | $-2.62M | $-2.51M | $-2.70M | $-3.39M |
| Low Forecast | $-2.10M | $-1.80M | $-1.50M | $-17.84M | $-1.00M | $-900.00K | $-900.00K | $-16.22M | $-600.00K | $-6.14M | $-1.00M | $-14.74M | $-4.01M | $-5.58M | $-6.17M | $-15.77M | $-1.30M | $-6.17M | $-7.16M | $-2.83M | $-900.00K | $-3.00M | $-3.12M | $-2.84M | $-3.17M | $-3.78M | $-3.93M | $-3.77M | $-4.05M | $-5.09M |
| Surprise % | - | - | - | - | - | 3.55% | - | 0.35% | 7.57% | 1.21% | 5.26% | 0.43% | 1.55% | 0.86% | 1.00% | 1.00% | 3.95% | 1.13% | 0.96% | 1.56% | 2.49% | 1.28% | 0.89% | 1.51% | 1.31% | 0.96% | 0.95% | 0.90% | 0.89% | 0.94% |
undefined analysts predict OPGN's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than OpGen's previous annual EBITDA (undefined) of $NaN.
OpGen Net Income Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 | Sep 17 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | - | 9 | 10 | 16 | 9 | 10 | 8 | 8 | 11 | 8 | 18 | 16 | 8 | 18 | 8 | 18 |
| Net Income | - | - | - | - | - | $-4.06M | - | $-7.02M | $-9.97M | $-14.69M | $-6.41M | $-7.76M | $-6.81M | $-6.06M | $-7.09M | $-14.85M | $-7.11M | $-7.68M | $-7.48M | $-3.95M | $-2.52M | $-3.48M | $-2.59M | $-3.85M | $-3.73M | $-3.26M | $-3.33M | $-3.05M | $-3.27M | $-4.21M |
| Avg Forecast | $-1.88M | $-2.14M | $-2.28M | $-16.80M | $-3.35M | $-5.76M | $-9.52M | $-15.27M | $-26.81M | $-7.71M | $-38.48M | $-13.89M | $-3.60M | $-7.01M | $-7.09M | $-14.85M | $-54.42M | $-6.82M | $-7.77M | $-2.53M | $-142.21M | $-2.72M | $-2.90M | $-2.55M | $-2.85M | $-3.37M | $-3.50M | $-3.37M | $-3.68M | $-4.47M |
| High Forecast | $-1.88M | $-2.14M | $-2.28M | $-13.44M | $-3.35M | $-5.76M | $-9.52M | $-12.22M | $-26.81M | $-6.17M | $-38.48M | $-11.11M | $-2.88M | $-5.61M | $-5.67M | $-11.88M | $-54.42M | $-5.46M | $-6.22M | $-2.03M | $-142.21M | $-2.18M | $-2.32M | $-2.04M | $-2.28M | $-2.70M | $-2.80M | $-2.70M | $-2.94M | $-3.58M |
| Low Forecast | $-1.88M | $-2.14M | $-2.28M | $-20.16M | $-3.35M | $-5.76M | $-9.52M | $-18.33M | $-26.81M | $-9.26M | $-38.48M | $-16.66M | $-4.32M | $-8.42M | $-8.50M | $-17.82M | $-54.42M | $-8.19M | $-9.32M | $-3.04M | $-142.21M | $-3.26M | $-3.48M | $-3.06M | $-3.42M | $-4.05M | $-4.20M | $-4.05M | $-4.41M | $-5.37M |
| Surprise % | - | - | - | - | - | 0.70% | - | 0.46% | 0.37% | 1.90% | 0.17% | 0.56% | 1.89% | 0.86% | 1.00% | 1.00% | 0.13% | 1.13% | 0.96% | 1.56% | 0.02% | 1.28% | 0.89% | 1.51% | 1.31% | 0.96% | 0.95% | 0.90% | 0.89% | 0.94% |
OpGen's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. OPGN's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
OpGen SG&A Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 | Sep 17 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | - | 9 | 10 | 16 | 9 | 10 | 8 | 8 | 11 | 8 | 18 | 16 | 8 | 18 | 8 | 18 |
| SG&A | - | - | - | - | - | $2.37M | - | $3.45M | $3.20M | $3.05M | $3.30M | $3.68M | $3.50M | $3.09M | $3.49M | $3.56M | $3.09M | $3.29M | $3.54M | $1.98M | $1.67M | $1.94M | $1.99M | $2.12M | $2.12M | $2.10M | $2.26M | $2.12M | $1.93M | $2.66M |
| Avg Forecast | $6.91M | $5.92M | $4.94M | $3.95M | $3.29M | $2.96M | $2.96M | $5.26M | $1.97M | $1.32M | $3.29M | $3.40M | $4.53M | $3.56M | $3.64M | $4.31M | $4.21M | $3.24M | $3.89M | $1.94M | $2.91M | $2.91M | $3.29M | $3.59M | $1.99M | $1.86M | $2.69M | $3.08M | $2.43M | $2.42M |
| High Forecast | $6.91M | $5.92M | $4.94M | $3.95M | $3.29M | $2.96M | $2.96M | $5.26M | $1.97M | $1.32M | $3.29M | $3.40M | $4.53M | $3.56M | $3.64M | $4.31M | $4.21M | $3.24M | $3.89M | $1.94M | $2.91M | $2.91M | $3.29M | $3.59M | $2.38M | $2.23M | $3.23M | $3.70M | $2.91M | $2.90M |
| Low Forecast | $6.91M | $5.92M | $4.94M | $3.95M | $3.29M | $2.96M | $2.96M | $5.26M | $1.97M | $1.32M | $3.29M | $3.40M | $4.53M | $3.56M | $3.64M | $4.31M | $4.21M | $3.24M | $3.89M | $1.94M | $2.91M | $2.91M | $3.29M | $3.59M | $1.59M | $1.48M | $2.15M | $2.47M | $1.94M | $1.93M |
| Surprise % | - | - | - | - | - | 0.80% | - | 0.66% | 1.62% | 2.32% | 1.00% | 1.08% | 0.77% | 0.87% | 0.96% | 0.83% | 0.73% | 1.02% | 0.91% | 1.02% | 0.57% | 0.66% | 0.60% | 0.59% | 1.07% | 1.13% | 0.84% | 0.69% | 0.80% | 1.10% |
OpGen's average Quarter SG&A projection for Dec 23 is $3.29M, based on 1 Wall Street analysts, with a range of $3.29M to $3.29M. The forecast indicates a 38.77% rise compared to OPGN last annual SG&A of $2.37M (Sep 23).
OpGen EPS Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 | Sep 17 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | 1 | 1 | - | - | - | - | - | - | - | - | - | - | 9 | 10 | 16 | 9 | 10 | 8 | 8 | 11 | 8 | 18 | 16 | 8 | 18 | 8 | 18 |
| EPS | - | - | - | - | - | $-0.46 | - | $-1.53 | $-4.08 | $-6.17 | $-2.75 | $-3.34 | $-3.37 | $-0.16 | $-0.19 | $-0.50 | $-0.34 | $-0.40 | $-0.49 | $-0.53 | $-0.61 | $-3.95 | $-3.00 | $-8.20 | $-9.40 | $-10.60 | $-11.40 | $-15.00 | $-35.00 | $-75.00 |
| Avg Forecast | $-1.40 | $-1.60 | $-1.70 | $-1.90 | $-2.50 | $-4.30 | $-7.10 | $-12.00 | $-20.00 | $-24.00 | $-30.00 | $-3.20 | $-3.10 | $-3.80 | $-3.90 | $-4.80 | $-6.20 | $-7.20 | $-10.20 | $-7.80 | $-16.20 | $-77.80 | $-68.00 | $-122.67 | $-5.80 | $-11.40 | $-12.60 | $-18.60 | $-45.00 | $-4.25 |
| High Forecast | $-1.40 | $-1.60 | $-1.70 | $-1.90 | $-2.50 | $-4.30 | $-7.10 | $-12.00 | $-20.00 | $-24.00 | $-30.00 | $-3.20 | $-3.10 | $-3.80 | $-3.90 | $-4.80 | $-6.20 | $-7.20 | $-10.20 | $-7.80 | $-16.20 | $-77.80 | $-68.00 | $-122.67 | $-4.64 | $-9.12 | $-10.08 | $-14.88 | $-36.00 | $-3.40 |
| Low Forecast | $-1.40 | $-1.60 | $-1.70 | $-1.90 | $-2.50 | $-4.30 | $-7.10 | $-12.00 | $-20.00 | $-24.00 | $-30.00 | $-3.20 | $-3.10 | $-3.80 | $-3.90 | $-4.80 | $-6.20 | $-7.20 | $-10.20 | $-7.80 | $-16.20 | $-77.80 | $-68.00 | $-122.67 | $-6.96 | $-13.68 | $-15.12 | $-22.32 | $-54.00 | $-5.10 |
| Surprise % | - | - | - | - | - | 0.11% | - | 0.13% | 0.20% | 0.26% | 0.09% | 1.04% | 1.09% | 0.04% | 0.05% | 0.10% | 0.05% | 0.06% | 0.05% | 0.07% | 0.04% | 0.05% | 0.04% | 0.07% | 1.62% | 0.93% | 0.90% | 0.81% | 0.78% | 17.65% |
According to undefined Wall Street analysts, OpGen's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to OPGN previous annual EPS of $NaN (undefined).
OpGen Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| BJDX | Bluejay Diagnostics | $0.15 | $10.00 | 6566.67% | Buy |
| VAPO | Vapotherm | $2.16 | $128.00 | 5825.93% | Hold |
| NPCE | NeuroPace | $7.43 | $12.88 | 73.35% | Buy |
| SGHT | Sight Sciences | $6.95 | $10.33 | 48.63% | Hold |
| HSCS | Heart Test Laboratories | $3.04 | $3.00 | -1.32% | Buy |
| OPGN | OpGen | $2.24 | $0.67 | -70.09% | Buy |
OPGN Forecast FAQ
Is OpGen a good buy?
Yes, according to 1 Wall Street analysts, OpGen (OPGN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of OPGN's total ratings.
What is OPGN's price target?
OpGen (OPGN) average price target is $0.67 with a range of $0.67 to $0.67, implying a -70.09% from its last price of $2.24. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will OpGen stock go up soon?
According to Wall Street analysts' prediction for OPGN stock, the company can go down by -70.09% (from the last price of $2.24 to the average price target of $0.67), down by -70.09% based on the highest stock price target, and down by -70.09% based on the lowest stock price target.
Can OpGen stock reach $3?
OPGN's average twelve months analyst stock price target of $0.67 does not support the claim that OpGen can reach $3 in the near future.
What are OpGen's analysts' financial forecasts?
OpGen's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $4.4M (high $4.4M, low $4.4M), average EBITDA is $-16.313M (high $-13.611M, low $-19.016M), average net income is $-33.904M (high $-30.849M, low $-36.959M), average SG&A $14.48M (high $14.48M, low $14.48M), and average EPS is $-25.9 (high $-25.9, low $-25.9). OPGN's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $6.6M (high $6.6M, low $6.6M), average EBITDA is $-20.264M (high $-17.292M, low $-23.237M), average net income is $-23.101M (high $-19.74M, low $-26.461M), average SG&A $21.71M (high $21.71M, low $21.71M), and average EPS is $-6.6 (high $-6.6, low $-6.6).
Did the OPGN's actual financial results beat the analysts' financial forecasts?
Based on OpGen's last annual report (Dec 2022), the company's revenue was $2.61M, which missed the average analysts forecast of $3.05M by -14.51%. Apple's EBITDA was $-22.172M, beating the average prediction of $-19.001M by 16.69%. The company's net income was $-36.743M, missing the average estimation of $-86.886M by -57.71%. Apple's SG&A was $13.23M, beating the average forecast of $9.98M by 32.55%. Lastly, the company's EPS was $-15.05, missing the average prediction of $-77.2 by -80.51%. In terms of the last quarterly report (Sep 2023), OpGen's revenue was $699.02K, missing the average analysts' forecast of $900K by -22.33%. The company's EBITDA was $-3.192M, beating the average prediction of $-900K by 254.66%. OpGen's net income was $-4.063M, missing the average estimation of $-5.763M by -29.50%. The company's SG&A was $2.37M, missing the average forecast of $2.96M by -19.93%. Lastly, the company's EPS was $-0.46, missing the average prediction of $-4.3 by -89.30%